Why the study?
Does intravenous verapamil improve reversion to sinus rhythm or rate control in patients with supraventricular tachyarrhythmias after a recent myocardial infarction?
Does intravenous verapamil improve reversion to sinus rhythm or rate control in patients with supraventricular tachyarrhythmias after a recent myocardial infarction?
Intravenous verapamil is effective for acute rate control and rhythm conversion of supraventricular tachyarrhythmias, particularly atrial flutter, early after acute myocardial infarction.
Answers are grounded in this paper and cite their sources.
May support verapamil for post-MI rate control; leaves open confirmation of rhythm conversion in randomized trials.
In 16 patients, a sustained supraventricular tachyarrhythmia occurring less than 72 hours after the first symptom of an acute myocardial infarction was treated with titrated doses of verapamil. The drug was given intravenously in 1 mg increments every minute under continuous monitoring of electrocardiogram and blood pressure. Endpoints for the administration of verapamil were the following: reversion to sinus rhythm; a ventricular rate slower than 100/min; hypotension; a pulmonary capillary wedge pressure rising above 15 mm Hg; signs of intolerance; a maximum dose of 20 mg. Reversion to sinus rhythm was observed in 7/8 patients in atrial flutter and in 1/8 patients in atrial fibrillation; in all the ventricular rate could be slowed below 100/min without untoward effects.
No takes yet. Share an insight, caveat, or question.
F Hagemeijer (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: